August 8, 2025 | clinical trials, oncology, patient recruitment
Boosting screening & enrollment rates in a global oncology trial

This Phase III global clinical trial for patients with either stage IIIB or IV unresectable melanoma involved 118 research sites across 25 countries. For this particular study, the sponsor had never run an oncology study before, so we were commissioned to provide in-country support to help sites overcome patient recruitment challenges.
This content was provided by Innovative Trials
Company Details
Latest Content from Innovative Trials
Global patient recruitment Innovative Trials took part of the PMEA Awards gala dinner alongside the best players in the pharmaceutical industry.
Innovative Trials has unveiled a new partnership with the non-profit Oliver Patch Project to boost retention in pediatric studies.
Innovative Trials achievements recognized at the Lloyds Bank British Business Excellence Awards
Innovative Trials finalist in the Support Agency of the Year at the annual PMEA industry awards.
Join Innovative Trials and Avillion in this FREE webinar
Innovative Trials launches ‘first of its kind’ service to boost clinical trial patient recruitment and retention .
Welcome to the new era in patient recruitment and retention
The patient recruitment company has chosen their UK charity partner for 2022/2023
UK-based patient recruitment company celebrates an incredible achievement in a national award nomination
